Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Karch, André ^a,b   Manthey, Henrike ^a   Ponto, Claudia ^a   Hermann, Peter ^a   Heinemann, Uta ^a   Schmidt, Christian ^a   Zerr, Inga ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MODEL; BLOOD BRAIN BARRIER; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MULTIINFARCT DEMENTIA; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BLOOD-BRAIN BARRIER; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA, VASCULAR; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; RETROSPECTIVE STUDIES;

EID: 84893589693     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084405     Document Type: Article

References (27)

1. Bickeboller H, Campion D, Brice A, Amouyel P, Hannequin D, et al. (1997) Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 60: 439-446. (Pubitemid 27058416)
2. Izaks GJ, Gansevoort RT, van der Knaap AM, Navis G, Dullaart RP, et al. (2011) The association of APOE genotype with cognitive function in persons aged 35 years or older. PLoS One 6: e27415.
3. Pardo LM, van Duijn CM (2005) In search of genes involved in neurodegenerative disorders. Mutat Res 592: 89-101. (Pubitemid 41714047)
4. Bu G (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10: 333-344.
5. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-516.
6. Carmeliet P, De Strooper B (2012) Alzheimer's disease: A breach in the blood-brain barrier. Nature 485: 451-452.
7. Wierenga CE, Clark LR, Dev SI, Shin DD, Jurick SM, et al. (2013) Interaction of Age and APOE Genotype on Cerebral Blood Flow at Rest. J Alzheimers Dis.
8. Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, et al. (2012) Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain 135: 3749-3756.
9. Hermann P., Romero C, Taraturo A, Zerr I (2009) CSF Biomarkers and Neuropsychology in patients with cerebral small vessel disease. 6th International Congress on Vascular Dementia, Barcelona.
10. Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, et al. (2007) Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 68: 1809-1814. (Pubitemid 46791393)
11. Donahue JE, Johanson CE (2008) Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease. J Neuropathol Exp Neurol 67: 261-270. (Pubitemid 351507482)
12. Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, et al. (1998) A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 50: 966-971. (Pubitemid 28212823)
13. Wada H (1998) Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. Intern Med 37: 509-513.
14. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, et al. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-746. (Pubitemid 47058377)
15. Schmidtke K, Hull M (2002) Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia. J Neurol Sci 203-204: 17-22. (Pubitemid 35287370)
16. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, et al. (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132: 2659-2668.
17. Mollenhauer B, Bibl M, Wiltfang J, Steinacker P, Ciesielczyk B, et al. (2006) Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies. Clin Chem Lab Med 44: 192-195. (Pubitemid 43237964)
18. Lunetta KL (2008) Genetic association studies. Circulation 118: 96-101.
19. Christensen H, Batterham PJ, Mackinnon AJ, Jorm AF, Mack HA, et al. (2008) The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample. BMC Geriatr 8: 14.
20. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, et al. (2011) APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16: 903-907.
21. Kolovou GD, Anagnostopoulou KK, Salpea KD, Panagiotakos DB, Hoursalas IS, et al. (2005) Apolipoprotein E genotype in matched men and women with coronary heart disease. Ann Clin Lab Sci 35: 391-396. (Pubitemid 41579568)
22. Reiber H (2003) Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21: 79-96.
23. Chen RL (2011) Is it appropriate to use albumin CSF/plasma ratio to assess blood brain barrier permeability? Neurobiol Aging 32: 1338-1339.
24. Farrall AJ, Wardlaw JM (2009) Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging 30: 337-352.
25. Pisani V, Stefani A, Pierantozzi M, Natoli S, Stanzione P, et al. (2012) Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease. J Neuroinflammation 9: 188.
26. Chalbot S, Zetterberg H, Blennow K, Fladby T, Andreasen N, et al. (2011) Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease. J Alzheimers Dis 25: 505-515.
27. Okamura T, Ishibashi N, Zurakowski D, Jonas RA (2010) Cardiopulmonary bypass increases permeability of the blood-cerebrospinal fluid barrier. Ann Thorac Surg 89: 187-194.